We are live on ! Find out more
HRTX icon

Heron Therapeutics

200 hedge funds and large institutions have $1.07B invested in Heron Therapeutics in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 66 increasing their positions, 57 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 26

21% more call options, than puts

Call options by funds: $12.5M | Put options by funds: $10.4M

16% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 57

8.95% more ownership

Funds ownership: 106.46%115.41% (+9%)

2% more funds holding

Funds holding: 197200 (+3)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

8% less capital invested

Capital invested by funds: $1.16B → $1.07B (-$87.7M)

Holders
200
Holders Change
+3
Holders Change %
+1.52%
% of All Funds
3.08%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
32
Increased
66
Reduced
57
Closed
26
Calls
$12.5M
Puts
$10.4M
Net Calls
+$2.14M
Net Calls Change
+$80K
Name Holding Trade Value Shares
Change
Change in
Stake
SC
101
Searle & Co
Connecticut
$436K
RAM
102
Redmond Asset Management
Virginia
$420K -$53.3K -5,224 -10%
WMSA
103
Weiss Multi-Strategy Advisers
New York
$388K +$222K +21,757 +105%
Royal Bank of Canada
104
Royal Bank of Canada
Ontario, Canada
$376K +$144K +14,059 +52%
State Board of Administration of Florida Retirement System
105
State Board of Administration of Florida Retirement System
Florida
$372K +$8.24K +807 +2%
Simplex Trading
106
Simplex Trading
Illinois
$354K +$376K +36,847 +1,837%
HF
107
HRT Financial
New York
$343K +$385K +37,662 New
VOYA Investment Management
108
VOYA Investment Management
Georgia
$333K -$2.16M -211,834 -85%
GCP
109
GSA Capital Partners
United Kingdom
$314K -$21.1K -2,068 -6%
MIM
110
MetLife Investment Management
New Jersey
$299K
T. Rowe Price Associates
111
T. Rowe Price Associates
Maryland
$274K -$239K -23,400 -44%
CL
112
CSS LLC
Illinois
$274K
SSA
113
Schonfeld Strategic Advisors
New York
$264K -$222K -21,700 -43%
BFM
114
Boothbay Fund Management
New York
$260K -$95.6K -9,368 -25%
Handelsbanken Fonder
115
Handelsbanken Fonder
Sweden
$256K
SM
116
SG3 Management
Puerto Rico
$255K +$285K +27,904 New
Principal Financial Group
117
Principal Financial Group
Iowa
$254K -$98.3K -9,628 -26%
BAM
118
Blueshift Asset Management
New Jersey
$251K +$281K +27,493 New
MLICM
119
Metropolitan Life Insurance Company (MetLife)
New York
$246K
ACM
120
AlphaCrest Capital Management
New York
$244K +$273K +26,755 New
TRCT
121
Tower Research Capital (TRC)
New York
$239K -$202K -19,807 -43%
ASRS
122
Arizona State Retirement System
Arizona
$238K -$3K -294 -1%
M&T Bank
123
M&T Bank
New York
$208K +$12.7K +1,243 +6%
Osaic Holdings
124
Osaic Holdings
Arizona
$189K -$221K -21,684 -51%
ProShare Advisors
125
ProShare Advisors
Maryland
$184K +$84.8K +8,308 +70%

HRTX Hedge Fund Activity: Q4 2021 in Review

200 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2021, worth a combined $1.07B — down 7.6% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new HRTX positions and 26 closed out — a net gain of 6 holders — while 66 added to existing stakes and 57 trimmed.

The largest buyer was UBS O'Connor, adding an estimated $16.8M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $17.1M sold.

  • 200 institutional investors held Heron Therapeutics (HRTX) as of Q4 2021, up from 197 in Q3 2021.
  • Funds reported $1.07B of Heron Therapeutics stock for Q4 2021, down 7.6% quarter-over-quarter.
  • 32 funds opened new Heron Therapeutics positions in Q4 2021 and 26 closed out, a net change of +6 holders.
  • The largest Heron Therapeutics buyer in Q4 2021 was UBS O'Connor, an estimated $16.8M added.
  • The largest Heron Therapeutics seller in Q4 2021 was Point72 Asset Management, an estimated $17.1M sold.

Based on aggregated 13F filings for Q4 2021.